National Health Investors (NHI) Depreciation Expense (2016 - 2025)
National Health Investors filings provide 17 years of Depreciation Expense readings, the most recent being $20.2 million for Q3 2025.
- On a quarterly basis, Depreciation Expense rose 13.78% to $20.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $78.0 million, a 11.59% increase, with the full-year FY2024 number at $71.4 million, up 2.1% from a year prior.
- Depreciation Expense hit $20.2 million in Q3 2025 for National Health Investors, up from $19.9 million in the prior quarter.
- In the past five years, Depreciation Expense ranged from a high of $20.8 million in Q1 2021 to a low of $17.1 million in Q4 2023.
- Median Depreciation Expense over the past 5 years was $17.8 million (2022), compared with a mean of $18.5 million.
- Biggest five-year swings in Depreciation Expense: decreased 13.97% in 2022 and later increased 13.88% in 2025.
- National Health Investors' Depreciation Expense stood at $19.3 million in 2021, then fell by 10.34% to $17.3 million in 2022, then dropped by 1.11% to $17.1 million in 2023, then grew by 9.17% to $18.7 million in 2024, then grew by 8.22% to $20.2 million in 2025.
- The last three reported values for Depreciation Expense were $20.2 million (Q3 2025), $19.9 million (Q2 2025), and $19.2 million (Q1 2025) per Business Quant data.